Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 05, 2026 1.394
October 02, 2026 1.381
October 01, 2026 1.340
September 30, 2026 1.241
September 29, 2026 1.327
September 28, 2026 1.264
September 25, 2026 1.641
September 24, 2026 1.556
September 23, 2026 1.552
September 22, 2026 1.574
September 21, 2026 1.588
September 18, 2026 1.529
September 17, 2026 1.511
September 16, 2026 1.511
September 15, 2026 1.466
September 14, 2026 1.565
September 11, 2026 1.570
September 10, 2026 1.524
September 09, 2026 1.623
September 08, 2026 1.664
September 04, 2026 1.641
September 03, 2026 1.668
September 02, 2026 1.583
September 01, 2026 1.641
August 31, 2026 1.763
Date Value
August 28, 2026 1.727
August 27, 2026 1.731
August 26, 2026 1.902
August 25, 2026 1.754
August 24, 2026 1.821
August 21, 2026 2.222
August 20, 2026 2.055
August 19, 2026 2.563
August 18, 2026 2.563
August 17, 2026 2.563
August 14, 2026 2.676
August 13, 2026 2.676
August 12, 2026 2.676
August 11, 2026 2.676
August 10, 2026 2.676
August 07, 2026 2.608
August 06, 2026 2.608
August 05, 2026 2.559
August 04, 2026 2.559
August 03, 2026 2.338
July 31, 2026 2.338
July 30, 2026 2.516
July 29, 2026 2.646
July 28, 2026 2.646
July 27, 2026 2.646

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novartis AG 6.202
Roche Holding AG --
Oculis Holding AG 1.980
Sandoz Group AG --
Galderma Group AG --

Price to Book Value Related Metrics

PS Ratio 29.99
PEG Ratio -0.0957
Price 3.18
Earnings Yield -277.1%
Market Cap 3.377M
PEGY Ratio -0.0957